雍禾医疗(02279)今日盘中股价大涨7%,引起了市场的广泛关注。
公司财报显示,2024年其全年亏损较2023年大幅收窄超过55%,成为当日这一涨幅的主要推手。这主要得益于近期公司积极优化门店网络布局及升级营销策略,使毛利润和毛利率较上一年度分别获得7-10%和3-5个百分点的增长。
作为国内领先的毛发医疗服务机构之一,雍禾医疗在近年业务发展遇阻,不断陷入亏损泥潭。去年业绩转亏已让投资者对其未来前景颇为忧心忡忡。此次亏损大幅收窄无疑为公司的健康发展注入了一针强心剂,令市场对其未来盈利能力重拾信心,投资情绪大为改善。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.